Ruibao Ren

Publication Activity (10 Years)

Years Active: 2021-2023
Publications (10 Years): 4

Top Topics

Acinetobacter Baumannii

Signaling Pathway

Top Venues

Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Cell death discovery

Journal of hematology & oncology

This page only lists publications with an associated author ORCID identifier.

Publications

Nannan Ning, Ziqi Shang, Zhi-Ping Liu, Zhizhou Xia, Yang Li, Ruibao Ren, Hongmei Wang, Yi Zhang
A novel microtubule inhibitor promotes tumor ferroptosis by attenuating SLC7A11/GPX4 signaling. Cell death discovery 9 (1) (2023)
Baoyuan Zhang, Yan Zhang, Jiangwei Zhang, Ping Liu, Bo Jiao, Zaiqi Wang, Ruibao Ren
Focal Adhesion Kinase (FAK) Inhibition Synergizes with KRAS G12C Inhibitors in Treating Cancer through the Regulation of the FAK-YAP Signaling. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (16) (2021)
Donghe Li, Yuyin Zhang, Qingsong Qiu, Jinzeng Wang, Xuemei Zhao, Bo Jiao, Xiuli Zhang, Shanhe Yu, Pengfei Xu, Yuqing Dan, Xinhua Xiao, Peihong Wang, Mingzhu Liu, Zhizhou Xia, Zhangsen Huang, Ruihong Zhang, Jiaoyang Li, Xi Xie, Yan Zhang, Chenxuan Liu, Ping Liu, Ruibao Ren
IRF8 Impacts Self-Renewal of Hematopoietic Stem Cells by Regulating TLR9 Signaling Pathway of Innate Immune Cells. Advanced science (Weinheim, Baden-Wurttemberg, Germany) 8 (19) (2021)
Peihong Wang, Xinhua Xiao, Yuyin Zhang, Baoyuan Zhang, Donghe Li, Mingzhu Liu, Xi Xie, Chenxuan Liu, Ping Liu, Ruibao Ren
A dual inhibitor overcomes drug-resistant FLT3-ITD acute myeloid leukemia. Journal of hematology & oncology 14 (1) (2021)